Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $1,416,574 (100.0% shares, 0.0% debt)

Holdings (29)

VTI VANGUARD INDEX FDS 22.3%

Value ($000) $315,647 Shares 1,038,550 Est. Cost $267.51 Unrealized —

BN BROOKFIELD CORP 10.2%

Value ($000) $144,162 Shares 2,330,830 Est. Cost $22.16 Unrealized +66.6%

ASML ASML HOLDING N V 9.4%

Value ($000) $132,899 Shares 165,836 Est. Cost $662.32 Unrealized —

CRM SALESFORCE INC 6.4%

Value ($000) $90,039 Shares 330,187 Est. Cost $205.72 Unrealized +29.3%

MIRM MIRUM PHARMACEUTICALS INC 5.4%

Value ($000) $76,338 Shares 1,500,055 Est. Cost $12.27 Unrealized +263.0%

EWTX EDGEWISE THERAPEUTICS INC 5.0%

Value ($000) $70,139 Shares 5,350,000 Est. Cost $18.02 Unrealized -20.0%

INSM INSMED INC 4.8%

Value ($000) $68,435 Shares 680,000 Est. Cost $23.10 Unrealized +231.0%

RXRX RECURSION PHARMACEUTICALS IN 3.5%

Value ($000) $48,906 Shares 9,665,128 Est. Cost $6.72 Unrealized -26.9%

CRNX CRINETICS PHARMACEUTICALS IN 3.1%

Value ($000) $44,578 Shares 1,550,000 Est. Cost $25.06 Unrealized +23.2%

BABA ALIBABA GROUP HLDG LTD 3.0%

Value ($000) $42,226 Shares 372,327 Est. Cost $165.09 Unrealized —

AVBP ARRIVENT BIOPHARMA INC 2.9%

Value ($000) $40,757 Shares 1,872,142 Est. Cost $20.52 Unrealized +1.2%

— MERUS N V 2.8%

Value ($000) $39,450 Shares 750,000 Est. Cost $56.95 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 2.6%

Value ($000) $36,280 Shares 660,000 Est. Cost $77.70 Unrealized -24.2%

— BLUEPRINT MEDICINES CORP 2.4%

Value ($000) $33,962 Shares 264,956 Est. Cost $74.93 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 2.3%

Value ($000) $33,272 Shares 2,380,000 Est. Cost $16.63 Unrealized -18.4%

PHVS PHARVARIS N V 2.1%

Value ($000) $30,360 Shares 1,725,000 Est. Cost $15.26 Unrealized +5.6%

PCVX VAXCYTE INC 2.1%

Value ($000) $29,784 Shares 916,160 Est. Cost $39.88 Unrealized -17.8%

CLDX CELLDEX THERAPEUTICS INC NEW 1.7%

Value ($000) $24,420 Shares 1,200,000 Est. Cost $34.88 Unrealized -44.2%

ZBIO ZENAS BIOPHARMA INC 1.5%

Value ($000) $21,803 Shares 2,250,000 Est. Cost $14.60 Unrealized -33.3%

ELVN ENLIVEN THERAPEUTICS INC 1.5%

Value ($000) $21,754 Shares 1,084,432 Est. Cost $18.93 Unrealized 0.0%

APGE APOGEE THERAPEUTICS INC 1.4%

Value ($000) $19,517 Shares 449,392 Est. Cost $38.04 Unrealized 0.0%

CBLL CERIBELL INC 1.2%

Value ($000) $16,857 Shares 900,000 Est. Cost $23.95 Unrealized -29.0%

VALN VALNEVA SE 1.0%

Value ($000) $13,466 Shares 2,375,000 Est. Cost $5.67 Unrealized —

FDMT 4D MOLECULAR THERAPEUTICS IN 0.5%

Value ($000) $7,420 Shares 2,000,000 Est. Cost $14.31 Unrealized -75.4%

IOBT IO BIOTECH INC 0.3%

Value ($000) $4,663 Shares 3,354,449 Est. Cost $6.26 Unrealized -81.7%

— LANZATECH GLOBAL INC 0.3%

Value ($000) $4,289 Shares 15,814,845 Est. Cost $3.88 Unrealized —

MQ MARQETA INC 0.2%

Value ($000) $2,574 Shares 441,558 Est. Cost $22.37 Unrealized -78.8%

ABCL ABCELLERA BIOLOGICS INC 0.2%

Value ($000) $2,238 Shares 652,529 Est. Cost $8.47 Unrealized -70.6%

GLTO GALECTO INC 0.0%

Value ($000) $341 Shares 99,913 Est. Cost $13.05 Unrealized -77.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	1,038,550	$315,647	22.3%	$267.51	—	TOTAL STK MKT	922908769
BN	BROOKFIELD CORP	2,330,830	$144,162	10.2%	$22.16	+66.6%	CL A LTD VT SH	11271J107
ASML	ASML HOLDING N V	165,836	$132,899	9.4%	$662.32	—	N Y REGISTRY SHS	N07059210
CRM	SALESFORCE INC	330,187	$90,039	6.4%	$205.72	+29.3%	COM	79466L302
MIRM	MIRUM PHARMACEUTICALS INC	1,500,055	$76,338	5.4%	$12.27	+263.0%	COM	604749101
EWTX	EDGEWISE THERAPEUTICS INC	5,350,000	$70,139	5.0%	$18.02	-20.0%	COM	28036F105
INSM	INSMED INC	680,000	$68,435	4.8%	$23.10	+231.0%	COM PAR $.01	457669307
RXRX	RECURSION PHARMACEUTICALS IN	9,665,128	$48,906	3.5%	$6.72	-26.9%	CL A	75629V104
CRNX	CRINETICS PHARMACEUTICALS IN	1,550,000	$44,578	3.1%	$25.06	+23.2%	COM	22663K107
BABA	ALIBABA GROUP HLDG LTD	372,327	$42,226	3.0%	$165.09	—	SPONSORED ADS	01609W102
AVBP	ARRIVENT BIOPHARMA INC	1,872,142	$40,757	2.9%	$20.52	+1.2%	COM	04272N102
—	MERUS N V	750,000	$39,450	2.8%	$56.95	—	COM	N5749R100
BMRN	BIOMARIN PHARMACEUTICAL INC	660,000	$36,280	2.6%	$77.70	-24.2%	COM	09061G101
—	BLUEPRINT MEDICINES CORP	264,956	$33,962	2.4%	$74.93	—	COM	09627Y109
VRDN	VIRIDIAN THERAPEUTICS INC	2,380,000	$33,272	2.3%	$16.63	-18.4%	COM	92790C104
PHVS	PHARVARIS N V	1,725,000	$30,360	2.1%	$15.26	+5.6%	COM	N69605108
PCVX	VAXCYTE INC	916,160	$29,784	2.1%	$39.88	-17.8%	COM	92243G108
CLDX	CELLDEX THERAPEUTICS INC NEW	1,200,000	$24,420	1.7%	$34.88	-44.2%	COM NEW	15117B202
ZBIO	ZENAS BIOPHARMA INC	2,250,000	$21,803	1.5%	$14.60	-33.3%	COM	98937L105
ELVN	ENLIVEN THERAPEUTICS INC	1,084,432	$21,754	1.5%	$18.93	0.0%	COM	29337E102
APGE	APOGEE THERAPEUTICS INC	449,392	$19,517	1.4%	$38.04	0.0%	COM	03770N101
CBLL	CERIBELL INC	900,000	$16,857	1.2%	$23.95	-29.0%	COM	15678C102
VALN	VALNEVA SE	2,375,000	$13,466	1.0%	$5.67	—	SPONSORED ADS	92025Y103
FDMT	4D MOLECULAR THERAPEUTICS IN	2,000,000	$7,420	0.5%	$14.31	-75.4%	COM	35104E100
IOBT	IO BIOTECH INC	3,354,449	$4,663	0.3%	$6.26	-81.7%	COM	449778109
—	LANZATECH GLOBAL INC	15,814,845	$4,289	0.3%	$3.88	—	COM	51655R101
MQ	MARQETA INC	441,558	$2,574	0.2%	$22.37	-78.8%	CLASS A COM	57142B104
ABCL	ABCELLERA BIOLOGICS INC	652,529	$2,238	0.2%	$8.47	-70.6%	COM	00288U106
GLTO	GALECTO INC	99,913	$341	0.0%	$13.05	-77.3%	COM NEW	36322Q206